ALLISON ELAINE GORREBEECK
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology AUSTIN, TX NPI 1467548628
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology TX Tempus AI, Inc All categories
General Payments — all program years on this page
$2,699.61
- Category: General Payments
- Program years: PY2018–2024
- Record count: 121
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $927.14 across 38 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $910.12 | 37 |
| Education | $17.02 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Tempus AI, Inc | $220.08 | 7 |
| PFIZER INC. | $155.35 | 7 |
| Celgene Corporation | $57.84 | 3 |
| Merck Sharp & Dohme Corporation | $54.78 | 2 |
| Gilead Sciences, Inc. | $53.31 | 2 |
| Acerta Pharma LLC | $45.23 | 2 |
| GENZYME CORPORATION | $40.15 | 1 |
| Janssen Biotech, Inc. | $39.61 | 1 |
| Coherus Biosciences Inc. | $28.12 | 1 |
| Ipsen Biopharmaceuticals, Inc | $24.06 | 1 |
| Alexion Pharmaceuticals, Inc. | $23.58 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.17 | 1 |
| Incyte Corporation | $22.13 | 1 |
| TAIHO ONCOLOGY, INC. | $21.66 | 1 |
| Stemline Therapeutics Inc. | $19.79 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.35 | 1 |
| Regeneron Healthcare Solutions, Inc. | $17.02 | 1 |
| ARRAY BIOPHARMA INC | $16.65 | 1 |
| Agios Pharmaceuticals, Inc. | $16.17 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $15.67 | 1 |
| SHIELD THERAPEUTICS INC | $14.42 | 1 |
By program year
Records — PY2024 (38)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.